AI-generated summary
The authors tested whether low-level laser therapy could enhance Biosilicate/PLGA composites, using cell cultures and tibial defects in 80 rats. They report higher fibroblast viability with the BS/PLGA composites after 24 hours and higher osteoblast viability with BS/PLGA plus laser at all periods. In rats, they report improved material degradation and more granulation tissue and newly formed bone with the combined treatment.
- Participants
- 80
- Who or what was studied
- 80 Wistar rats with tibial bone defects, plus fibroblast and osteoblast cell cultures
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract describes in vitro and animal work only, with no human data and no statistical details provided.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808nm
- Energy density (fluence)
- 10J/cm2, 30J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.